乘客突变在人类肺腺癌中将细胞起源和转录身份联系在一起
Sukanya Panja1,2, Padmaja Mantri1,2, Kofi Ennu Johnson2,3,4
1Cancer Genetics and Genomics Program, Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.
Nature genetics
|November 27, 2025
概括
这项研究将肺癌突变与正常细胞基因表达联系起来,揭示了肺腺癌和状细胞癌的潜在细胞起源. 这些发现有助于推断癌症中的瘤起源.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 癌症基因组中的体质突变模式可以与正常细胞转录相关.
- 这种相关性可能为各种瘤类型的起源细胞提供了洞察力.
研究的目的:
- 研究肺癌中体质突变密度和细胞类型特定基因表达之间的关系.
- 推断肺腺癌 (LUAD) 和肺状细胞癌 (LUSC) 的细胞起源.
主要方法:
- 在LUAD和LUSC中对全基因组体质突变模式的分析.
- 突变密度与正常肺细胞基因表达数据的相关性.
- 鉴定与推断细胞起源相关的突变特征和驱动突变.
主要成果:
- 总的突变密度在LUAD和LUSC与分别远端 (气囊) 和近端 (基底) 肺细胞表达相关.
- 21%的LUAD显示近距离的气道起源;38%是模两可的.
- 远端LUAD与KRAS/STK11司机和吸烟者有关;近端LUAD与EGFR司机和从未吸烟者有关.
- 模两可的LUAD显示了APOBEC签名和SMARCA4修改.
结论:
- 基于转录模式的瘤起源推断为癌症研究提供了一个可扩展的策略.
- 细胞谱系和转录特征之间的复杂相互作用影响了LUAD进化.
- 了解瘤的起源可以改进癌症的分类和治疗策略.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
Mutations
94.3K
Overview
94.3K
Mutations
42.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.6K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K


